Bolzati, C.; Gobbi, C.; Ferro-Flores, G.; Turato, S.; Ocampo-Garcia, B.; Carpanese, D.; Marzano, C.; Spolaore, B.; Fracasso, G.; Rosato, A.;
et al. Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. Int. J. Mol. Sci. 2024, 25, 492.
https://doi.org/10.3390/ijms25010492
AMA Style
Bolzati C, Gobbi C, Ferro-Flores G, Turato S, Ocampo-Garcia B, Carpanese D, Marzano C, Spolaore B, Fracasso G, Rosato A,
et al. Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. International Journal of Molecular Sciences. 2024; 25(1):492.
https://doi.org/10.3390/ijms25010492
Chicago/Turabian Style
Bolzati, Cristina, Carolina Gobbi, Guillermina Ferro-Flores, Sofia Turato, Blanca Ocampo-Garcia, Debora Carpanese, Cristina Marzano, Barbara Spolaore, Giulio Fracasso, Antonio Rosato,
and et al. 2024. "Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer" International Journal of Molecular Sciences 25, no. 1: 492.
https://doi.org/10.3390/ijms25010492
APA Style
Bolzati, C., Gobbi, C., Ferro-Flores, G., Turato, S., Ocampo-Garcia, B., Carpanese, D., Marzano, C., Spolaore, B., Fracasso, G., Rosato, A., & Meléndez-Alafort, L.
(2024). Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer. International Journal of Molecular Sciences, 25(1), 492.
https://doi.org/10.3390/ijms25010492
